{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T15:46:33Z","timestamp":1778859993691,"version":"3.51.4"},"reference-count":94,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T00:00:00Z","timestamp":1657238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T00:00:00Z","timestamp":1657238400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["R01 AR071439"],"award-info":[{"award-number":["R01 AR071439"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["R01 AR078571"],"award-info":[{"award-number":["R01 AR078571"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["R01 AR078624"],"award-info":[{"award-number":["R01 AR078624"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"published-print":{"date-parts":[[2022,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Muscular dystrophy encompasses a large number of heterogeneous genetic disorders characterized by progressive and devastating muscle wasting. Cell-based replacement strategies aimed at promoting skeletal muscle regeneration represent a candidate therapeutic approach to treat muscular dystrophies. Due to the difficulties of obtaining large numbers of stem cells from a muscle biopsy as well as expanding these in vitro, pluripotent stem cells (PSCs) represent an attractive cell source for the generation of myogenic progenitors, given that PSCs can repeatedly produce large amounts of lineage-specific tissue, representing an unlimited source of cells for therapy. In this review, we focus on the progress to date on different methods for the generation of human PSC-derived myogenic progenitor cells, their regenerative capabilities upon transplantation, their potential for allogeneic and autologous transplantation, as well as the specific challenges to be considered for future therapeutic applications.<\/jats:p>","DOI":"10.1007\/s00018-022-04434-8","type":"journal-article","created":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T13:04:08Z","timestamp":1657285448000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Generation of human myogenic progenitors from pluripotent stem cells for in vivo regeneration"],"prefix":"10.1007","volume":"79","author":[{"given":"Hyunkee","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9412-1118","authenticated-orcid":false,"given":"Rita C. R.","family":"Perlingeiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,7,8]]},"reference":[{"issue":"9307","key":"4434_CR1","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/s0140-6736(02)07815-7","volume":"359","author":"AEH Emery","year":"2002","unstructured":"Emery AEH (2002) The muscular dystrophies. Lancet 359(9307):687\u2013695. https:\/\/doi.org\/10.1016\/s0140-6736(02)07815-7","journal-title":"Lancet"},{"key":"4434_CR2","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1146\/annurev.pathol.2.010506.091936","volume":"2","author":"EM McNally","year":"2007","unstructured":"McNally EM, Pytel P (2007) Muscle diseases: the muscular dystrophies. Annu Rev Pathol 2:87\u2013109. https:\/\/doi.org\/10.1146\/annurev.pathol.2.010506.091936","journal-title":"Annu Rev Pathol"},{"issue":"9869","key":"4434_CR3","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/s0140-6736(12)61897-2","volume":"381","author":"E Mercuri","year":"2013","unstructured":"Mercuri E, Muntoni F (2013) Muscular dystrophies. Lancet 381(9869):845\u2013860. https:\/\/doi.org\/10.1016\/s0140-6736(12)61897-2","journal-title":"Lancet"},{"issue":"3\u20134","key":"4434_CR4","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1159\/000369343","volume":"43","author":"A Theadom","year":"2014","unstructured":"Theadom A, Rodrigues M, Roxburgh R, Balalla S, Higgins C, Bhattacharjee R, Jones K, Krishnamurthi R, Feigin V (2014) Prevalence of muscular dystrophies: a systematic literature review. Neuroepidemiology 43(3\u20134):259\u2013268. https:\/\/doi.org\/10.1159\/000369343","journal-title":"Neuroepidemiology"},{"issue":"10213","key":"4434_CR5","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1016\/s0140-6736(19)32910-1","volume":"394","author":"E Mercuri","year":"2019","unstructured":"Mercuri E, B\u00f6nnemann CG, Muntoni F (2019) Muscular dystrophies. Lancet 394(10213):2025\u20132038. https:\/\/doi.org\/10.1016\/s0140-6736(19)32910-1","journal-title":"Lancet"},{"issue":"6","key":"4434_CR6","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1097\/MOP.0b013e328365ace5","volume":"25","author":"E Mercuri","year":"2013","unstructured":"Mercuri E, Muntoni F (2013) Muscular dystrophy: new challenges and review of the current clinical trials. Curr Opin Pediatr 25(6):701\u2013707. https:\/\/doi.org\/10.1097\/MOP.0b013e328365ace5","journal-title":"Curr Opin Pediatr"},{"issue":"1","key":"4434_CR7","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1017\/cjn.2015.311","volume":"43","author":"JK Mah","year":"2016","unstructured":"Mah JK, Korngut L, Fiest KM, Dykeman J, Day LJ, Pringsheim T, Jette N (2016) A systematic review and meta-analysis on the epidemiology of the muscular dystrophies. Can J Neurol Sci 43(1):163\u2013177. https:\/\/doi.org\/10.1017\/cjn.2015.311","journal-title":"Can J Neurol Sci"},{"issue":"6","key":"4434_CR8","doi-asserted-by":"publisher","first-page":"610","DOI":"10.3892\/etm.2021.10042","volume":"21","author":"G Gaina","year":"2021","unstructured":"Gaina G, Popa Gruianu A (2021) Muscular dystrophy: experimental animal models and therapeutic approaches (review). Exp Ther Med 21(6):610. https:\/\/doi.org\/10.3892\/etm.2021.10042","journal-title":"Exp Ther Med"},{"issue":"10","key":"4434_CR9","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1089\/hum.2018.151","volume":"29","author":"F Galli","year":"2018","unstructured":"Galli F, Bragg L, Meggiolaro L, Rossi M, Caffarini M, Naz N, Santoleri S, Cossu G (2018) Gene and cell therapy for muscular dystrophies: are we getting there? Hum Gene Ther 29(10):1098\u20131105. https:\/\/doi.org\/10.1089\/hum.2018.151","journal-title":"Hum Gene Ther"},{"issue":"2","key":"4434_CR10","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1172\/jci117011","volume":"93","author":"J Huard","year":"1994","unstructured":"Huard J, Verreault S, Roy R, Tremblay M, Tremblay JP (1994) High efficiency of muscle regeneration after human myoblast clone transplantation in SCID mice. J Clin Invest 93(2):586\u2013599. https:\/\/doi.org\/10.1172\/jci117011","journal-title":"J Clin Invest"},{"issue":"6203","key":"4434_CR11","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/337176a0","volume":"337","author":"TA Partridge","year":"1989","unstructured":"Partridge TA, Morgan JE, Coulton GR, Hoffman EP, Kunkel LM (1989) Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblasts. Nature 337(6203):176\u2013179. https:\/\/doi.org\/10.1038\/337176a0","journal-title":"Nature"},{"issue":"12","key":"4434_CR12","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1097\/00007890-199906270-00018","volume":"67","author":"V Brussee","year":"1999","unstructured":"Brussee V, Tardif F, Roy B, Goulet M, Sebille A, Tremblay JP (1999) Successful myoblast transplantation in fibrotic muscles: no increased impairment by the connective tissue. Transplantation 67(12):1618\u20131622. https:\/\/doi.org\/10.1097\/00007890-199906270-00018","journal-title":"Transplantation"},{"issue":"9","key":"4434_CR13","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1038\/nm0997-970","volume":"3","author":"E Gussoni","year":"1997","unstructured":"Gussoni E, Blau HM, Kunkel LM (1997) The fate of individual myoblasts after transplantation into muscles of DMD patients. Nat Med 3(9):970\u2013977. https:\/\/doi.org\/10.1038\/nm0997-970","journal-title":"Nat Med"},{"issue":"5","key":"4434_CR14","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1002\/mus.880150504","volume":"15","author":"J Huard","year":"1992","unstructured":"Huard J, Bouchard JP, Roy R, Malouin F, Dansereau G, Labrecque C, Albert N, Richards CL, Lemieux B, Tremblay JP (1992) Human myoblast transplantation: preliminary results of 4 cases. Muscle Nerve 15(5):550\u2013560. https:\/\/doi.org\/10.1002\/mus.880150504","journal-title":"Muscle Nerve"},{"issue":"2\u20133","key":"4434_CR15","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1177\/0963689792001002-305","volume":"1","author":"PK Law","year":"1992","unstructured":"Law PK, Goodwin TG, Fang Q, Duggirala V, Larkin C, Florendo JA, Kirby DS, Deering MB, Li HJ, Chen M et al (1992) Feasibility, safety, and efficacy of myoblast transfer therapy on Duchenne muscular dystrophy boys. Cell Transplant 1(2\u20133):235\u2013244. https:\/\/doi.org\/10.1177\/0963689792001002-305","journal-title":"Cell Transplant"},{"issue":"13","key":"4434_CR16","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1056\/nejm199509283331303","volume":"333","author":"JR Mendell","year":"1995","unstructured":"Mendell JR, Kissel JT, Amato AA, King W, Signore L, Prior TW, Sahenk Z, Benson S, McAndrew PE, Rice R et al (1995) Myoblast transfer in the treatment of Duchenne\u2019s muscular dystrophy. N Engl J Med 333(13):832\u2013838. https:\/\/doi.org\/10.1056\/nejm199509283331303","journal-title":"N Engl J Med"},{"issue":"2","key":"4434_CR17","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1177\/096368979300200203","volume":"2","author":"JP Tremblay","year":"1993","unstructured":"Tremblay JP, Malouin F, Roy R, Huard J, Bouchard JP, Satoh A, Richards CL (1993) Results of a triple blind clinical study of myoblast transplantations without immunosuppressive treatment in young boys with Duchenne muscular dystrophy. Cell Transplant 2(2):99\u2013112. https:\/\/doi.org\/10.1177\/096368979300200203","journal-title":"Cell Transplant"},{"issue":"2","key":"4434_CR18","first-page":"119","volume":"24","author":"JT Vilquin","year":"2005","unstructured":"Vilquin JT (2005) Myoblast transplantation: clinical trials and perspectives. Mini-review. Acta Myol 24(2):119\u2013127","journal-title":"Acta Myol"},{"issue":"11","key":"4434_CR19","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1038\/3167","volume":"4","author":"T Partridge","year":"1998","unstructured":"Partridge T, Lu QL, Morris G, Hoffman E (1998) Is myoblast transplantation effective? Nat Med 4(11):1208\u20131209. https:\/\/doi.org\/10.1038\/3167","journal-title":"Nat Med"},{"issue":"5","key":"4434_CR20","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1083\/jcb.142.5.1257","volume":"142","author":"Z Qu","year":"1998","unstructured":"Qu Z, Balkir L, van Deutekom JC, Robbins PD, Pruchnic R, Huard J (1998) Development of approaches to improve cell survival in myoblast transfer therapy. J Cell Biol 142(5):1257\u20131267. https:\/\/doi.org\/10.1083\/jcb.142.5.1257","journal-title":"J Cell Biol"},{"issue":"6","key":"4434_CR21","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/s0092-8674(00)00066-0","volume":"102","author":"P Seale","year":"2000","unstructured":"Seale P, Sabourin LA, Girgis-Gabardo A, Mansouri A, Gruss P, Rudnicki MA (2000) Pax7 is required for the specification of myogenic satellite cells. Cell 102(6):777\u2013786. https:\/\/doi.org\/10.1016\/s0092-8674(00)00066-0","journal-title":"Cell"},{"issue":"12","key":"4434_CR22","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1038\/sj.mt.6300295","volume":"15","author":"M Ikemoto","year":"2007","unstructured":"Ikemoto M, Fukada S, Uezumi A, Masuda S, Miyoshi H, Yamamoto H, Wada MR, Masubuchi N, Miyagoe-Suzuki Y, Takeda S (2007) Autologous transplantation of SM\/C-26(+) satellite cells transduced with micro-dystrophin CS1 cDNA by lentiviral vector into mdx mice. Mol Ther 15(12):2178\u20132185. https:\/\/doi.org\/10.1038\/sj.mt.6300295","journal-title":"Mol Ther"},{"issue":"5743","key":"4434_CR23","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1126\/science.1114758","volume":"309","author":"D Montarras","year":"2005","unstructured":"Montarras D, Morgan J, Collins C, Relaix F, Zaffran S, Cumano A, Partridge T, Buckingham M (2005) Direct isolation of satellite cells for skeletal muscle regeneration. Science 309(5743):2064\u20132067. https:\/\/doi.org\/10.1126\/science.1114758","journal-title":"Science"},{"issue":"1","key":"4434_CR24","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.stemcr.2021.11.012","volume":"17","author":"M Arjona","year":"2022","unstructured":"Arjona M, Goshayeshi A, Rodriguez-Mateo C, Brett JO, Both P, Ishak H, Rando TA (2022) Tubastatin A maintains adult skeletal muscle stem cells in a quiescent state ex vivo and improves their engraftment ability in vivo. Stem Cell Rep 17(1):82\u201395. https:\/\/doi.org\/10.1016\/j.stemcr.2021.11.012","journal-title":"Stem Cell Rep"},{"issue":"1","key":"4434_CR25","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1083\/jcb.201310035","volume":"205","author":"CF Bentzinger","year":"2014","unstructured":"Bentzinger CF, von Maltzahn J, Dumont NA, Stark DA, Wang YX, Nhan K, Frenette J, Cornelison DD, Rudnicki MA (2014) Wnt7a stimulates myogenic stem cell motility and engraftment resulting in improved muscle strength. J Cell Biol 205(1):97\u2013111. https:\/\/doi.org\/10.1083\/jcb.201310035","journal-title":"J Cell Biol"},{"issue":"1","key":"4434_CR26","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.stem.2012.09.015","volume":"12","author":"CF Bentzinger","year":"2013","unstructured":"Bentzinger CF, Wang YX, von Maltzahn J, Soleimani VD, Yin H, Rudnicki MA (2013) Fibronectin regulates Wnt7a signaling and satellite cell expansion. Cell Stem Cell 12(1):75\u201387. https:\/\/doi.org\/10.1016\/j.stem.2012.09.015","journal-title":"Cell Stem Cell"},{"issue":"5995","key":"4434_CR27","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1126\/science.1191035","volume":"329","author":"PM Gilbert","year":"2010","unstructured":"Gilbert PM, Havenstrite KL, Magnusson KE, Sacco A, Leonardi NA, Kraft P, Nguyen NK, Thrun S, Lutolf MP, Blau HM (2010) Substrate elasticity regulates skeletal muscle stem cell self-renewal in culture. Science 329(5995):1078\u20131081. https:\/\/doi.org\/10.1126\/science.1191035","journal-title":"Science"},{"issue":"2","key":"4434_CR28","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.stem.2017.12.010","volume":"22","author":"RN Judson","year":"2018","unstructured":"Judson RN, Quarta M, Oudhoff MJ, Soliman H, Yi L, Chang CK, Loi G, Vander Werff R, Cait A, Hamer M, Blonigan J, Paine P, Doan LTN, Groppa E, He W, Su L, Zhang RH, Xu P, Eisner C, Low M, Barta I, Lewis CB, Zaph C, Karimi MM, Rando TA, Rossi FM (2018) Inhibition of methyltransferase Setd7 allows the in vitro expansion of myogenic stem cells with improved therapeutic potential. Cell Stem Cell 22(2):177-190.e177. https:\/\/doi.org\/10.1016\/j.stem.2017.12.010","journal-title":"Cell Stem Cell"},{"issue":"10","key":"4434_CR29","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1038\/nm.3655","volume":"20","author":"FD Price","year":"2014","unstructured":"Price FD, von Maltzahn J, Bentzinger CF, Dumont NA, Yin H, Chang NC, Wilson DH, Frenette J, Rudnicki MA (2014) Inhibition of JAK-STAT signaling stimulates adult satellite cell function. Nat Med 20(10):1174\u20131181. https:\/\/doi.org\/10.1038\/nm.3655","journal-title":"Nat Med"},{"issue":"10","key":"4434_CR30","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1038\/nm.3656","volume":"20","author":"MT Tierney","year":"2014","unstructured":"Tierney MT, Aydogdu T, Sala D, Malecova B, Gatto S, Puri PL, Latella L, Sacco A (2014) STAT3 signaling controls satellite cell expansion and skeletal muscle repair. Nat Med 20(10):1182\u20131186. https:\/\/doi.org\/10.1038\/nm.3656","journal-title":"Nat Med"},{"key":"4434_CR31","doi-asserted-by":"publisher","first-page":"702547","DOI":"10.3389\/fgene.2021.702547","volume":"12","author":"O Boyer","year":"2021","unstructured":"Boyer O, Butler-Browne G, Chinoy H, Cossu G, Galli F, Lilleker JB, Magli A, Mouly V, Perlingeiro RCR, Previtali SC, Sampaolesi M, Smeets H, Schoewel-Wolf V, Spuler S, Torrente Y, Van Tienen F, Study G (2021) Myogenic cell transplantation in genetic and acquired diseases of skeletal muscle. Front Genet 12:702547. https:\/\/doi.org\/10.3389\/fgene.2021.702547","journal-title":"Front Genet"},{"issue":"5391","key":"4434_CR32","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1126\/science.282.5391.1145","volume":"282","author":"JA Thomson","year":"1998","unstructured":"Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM (1998) Embryonic stem cell lines derived from human blastocysts. Science 282(5391):1145\u20131147. https:\/\/doi.org\/10.1126\/science.282.5391.1145","journal-title":"Science"},{"issue":"1","key":"4434_CR33","doi-asserted-by":"publisher","first-page":"hoy024","DOI":"10.1093\/hropen\/hoy024","volume":"2019","author":"C Eguizabal","year":"2019","unstructured":"Eguizabal C, Aran B, Chuva-de-Sousa-Lopes SM, Geens M, Heindryckx B, Panula S, Popovic M, Vassena R, Veiga A (2019) Two decades of embryonic stem cells: a historical overview. Hum Reprod Open 2019(1):hoy024. https:\/\/doi.org\/10.1093\/hropen\/hoy024","journal-title":"Hum Reprod Open"},{"issue":"5","key":"4434_CR34","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","volume":"131","author":"K Takahashi","year":"2007","unstructured":"Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131(5):861\u2013872. https:\/\/doi.org\/10.1016\/j.cell.2007.11.019","journal-title":"Cell"},{"issue":"4","key":"4434_CR35","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","volume":"126","author":"K Takahashi","year":"2006","unstructured":"Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126(4):663\u2013676. https:\/\/doi.org\/10.1016\/j.cell.2006.07.024","journal-title":"Cell"},{"issue":"3","key":"4434_CR36","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.stem.2007.08.008","volume":"1","author":"R Blelloch","year":"2007","unstructured":"Blelloch R, Venere M, Yen J, Ramalho-Santos M (2007) Generation of induced pluripotent stem cells in the absence of drug selection. Cell Stem Cell 1(3):245\u2013247. https:\/\/doi.org\/10.1016\/j.stem.2007.08.008","journal-title":"Cell Stem Cell"},{"issue":"7169","key":"4434_CR37","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/nature06357","volume":"450","author":"JA Byrne","year":"2007","unstructured":"Byrne JA, Pedersen DA, Clepper LL, Nelson M, Sanger WG, Gokhale S, Wolf DP, Mitalipov SM (2007) Producing primate embryonic stem cells by somatic cell nuclear transfer. Nature 450(7169):497\u2013502. https:\/\/doi.org\/10.1038\/nature06357","journal-title":"Nature"},{"issue":"5","key":"4434_CR38","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.cell.2008.07.041","volume":"134","author":"IH Park","year":"2008","unstructured":"Park IH, Arora N, Huo H, Maherali N, Ahfeldt T, Shimamura A, Lensch MW, Cowan C, Hochedlinger K, Daley GQ (2008) Disease-specific induced pluripotent stem cells. Cell 134(5):877\u2013886. https:\/\/doi.org\/10.1016\/j.cell.2008.07.041","journal-title":"Cell"},{"issue":"7175","key":"4434_CR39","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/nature06534","volume":"451","author":"IH Park","year":"2008","unstructured":"Park IH, Zhao R, West JA, Yabuuchi A, Huo H, Ince TA, Lerou PH, Lensch MW, Daley GQ (2008) Reprogramming of human somatic cells to pluripotency with defined factors. Nature 451(7175):141\u2013146. https:\/\/doi.org\/10.1038\/nature06534","journal-title":"Nature"},{"issue":"7151","key":"4434_CR40","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/nature05944","volume":"448","author":"M Wernig","year":"2007","unstructured":"Wernig M, Meissner A, Foreman R, Brambrink T, Ku M, Hochedlinger K, Bernstein BE, Jaenisch R (2007) In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 448(7151):318\u2013324. https:\/\/doi.org\/10.1038\/nature05944","journal-title":"Nature"},{"issue":"5858","key":"4434_CR41","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1126\/science.1151526","volume":"318","author":"J Yu","year":"2007","unstructured":"Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, Nie J, Jonsdottir GA, Ruotti V, Stewart R, Slukvin II, Thomson JA (2007) Induced pluripotent stem cell lines derived from human somatic cells. Science 318(5858):1917\u20131920. https:\/\/doi.org\/10.1126\/science.1151526","journal-title":"Science"},{"issue":"4","key":"4434_CR42","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.stem.2020.09.014","volume":"27","author":"S Yamanaka","year":"2020","unstructured":"Yamanaka S (2020) Pluripotent stem cell-based cell therapy-promise and challenges. Cell Stem Cell 27(4):523\u2013531. https:\/\/doi.org\/10.1016\/j.stem.2020.09.014","journal-title":"Cell Stem Cell"},{"issue":"1","key":"4434_CR43","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1007\/s12015-021-10262-3","volume":"18","author":"JY Kim","year":"2022","unstructured":"Kim JY, Nam Y, Rim YA, Ju JH (2022) Review of the current trends in clinical trials involving induced pluripotent stem cells. Stem Cell Rev Rep 18(1):142\u2013154. https:\/\/doi.org\/10.1007\/s12015-021-10262-3","journal-title":"Stem Cell Rev Rep"},{"issue":"5","key":"4434_CR44","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/nm1533","volume":"13","author":"T Barberi","year":"2007","unstructured":"Barberi T, Bradbury M, Dincer Z, Panagiotakos G, Socci ND, Studer L (2007) Derivation of engraftable skeletal myoblasts from human embryonic stem cells. Nat Med 13(5):642\u2013648. https:\/\/doi.org\/10.1038\/nm1533","journal-title":"Nat Med"},{"issue":"12","key":"4434_CR45","doi-asserted-by":"publisher","first-page":"e51638","DOI":"10.1371\/journal.pone.0051638","volume":"7","author":"T Awaya","year":"2012","unstructured":"Awaya T, Kato T, Mizuno Y, Chang H, Niwa A, Umeda K, Nakahata T, Heike T (2012) Selective development of myogenic mesenchymal cells from human embryonic and induced pluripotent stem cells. PLoS ONE 7(12):e51638. https:\/\/doi.org\/10.1371\/journal.pone.0051638","journal-title":"PLoS ONE"},{"issue":"3","key":"4434_CR46","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.stemcr.2014.07.001","volume":"3","author":"M Shelton","year":"2014","unstructured":"Shelton M, Metz J, Liu J, Carpenedo RL, Demers SP, Stanford WL, Skerjanc IS (2014) Derivation and expansion of PAX7-positive muscle progenitors from human and mouse embryonic stem cells. Stem Cell Rep 3(3):516\u2013529. https:\/\/doi.org\/10.1016\/j.stemcr.2014.07.001","journal-title":"Stem Cell Rep"},{"issue":"4","key":"4434_CR47","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/j.cell.2013.10.023","volume":"155","author":"C Xu","year":"2013","unstructured":"Xu C, Tabebordbar M, Iovino S, Ciarlo C, Liu J, Castiglioni A, Price E, Liu M, Barton ER, Kahn CR, Wagers AJ, Zon LI (2013) A zebrafish embryo culture system defines factors that promote vertebrate myogenesis across species. Cell 155(4):909\u2013921. https:\/\/doi.org\/10.1016\/j.cell.2013.10.023","journal-title":"Cell"},{"issue":"5","key":"4434_CR48","doi-asserted-by":"publisher","first-page":"564","DOI":"10.5966\/sctm.2013-0143","volume":"3","author":"T Hosoyama","year":"2014","unstructured":"Hosoyama T, McGivern JV, Van Dyke JM, Ebert AD, Suzuki M (2014) Derivation of myogenic progenitors directly from human pluripotent stem cells using a sphere-based culture. Stem Cells Transl Med 3(5):564\u2013574. https:\/\/doi.org\/10.5966\/sctm.2013-0143","journal-title":"Stem Cells Transl Med"},{"key":"4434_CR49","doi-asserted-by":"publisher","first-page":"1376151","DOI":"10.1155\/2017\/1376151","volume":"2017","author":"Y Kodaka","year":"2017","unstructured":"Kodaka Y, Rabu G, Asakura A (2017) Skeletal muscle cell induction from pluripotent stem cells. Stem Cells Int 2017:1376151. https:\/\/doi.org\/10.1155\/2017\/1376151","journal-title":"Stem Cells Int"},{"key":"4434_CR50","doi-asserted-by":"publisher","unstructured":"Nogami Ki, Blanc M, Takemura F, Takeda Si, Miyagoe-Suzuki Y (2018) Making skeletal muscle from human pluripotent stem cells. In: Muscle cell and tissue\u2014current status of research field. https:\/\/doi.org\/10.5772\/intechopen.77263","DOI":"10.5772\/intechopen.77263"},{"issue":"1","key":"4434_CR51","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s40659-020-00288-1","volume":"53","author":"R He","year":"2020","unstructured":"He R, Li H, Wang L, Li Y, Zhang Y, Chen M, Zhu Y, Zhang C (2020) Engraftment of human induced pluripotent stem cell-derived myogenic progenitors restores dystrophin in mice with duchenne muscular dystrophy. Biol Res 53(1):22. https:\/\/doi.org\/10.1186\/s40659-020-00288-1","journal-title":"Biol Res"},{"issue":"9","key":"4434_CR52","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1038\/nbt.3297","volume":"33","author":"J Chal","year":"2015","unstructured":"Chal J, Oginuma M, Al Tanoury Z, Gobert B, Sumara O, Hick A, Bousson F, Zidouni Y, Mursch C, Moncuquet P, Tassy O, Vincent S, Miyanari A, Bera A, Garnier JM, Guevara G, Hestin M, Kennedy L, Hayashi S, Drayton B, Cherrier T, Gayraud-Morel B, Gussoni E, Relaix F, Tajbakhsh S, Pourquie O (2015) Differentiation of pluripotent stem cells to muscle fiber to model Duchenne muscular dystrophy. Nat Biotechnol 33(9):962\u2013969. https:\/\/doi.org\/10.1038\/nbt.3297","journal-title":"Nat Biotechnol"},{"issue":"10","key":"4434_CR53","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1038\/nprot.2016.110","volume":"11","author":"J Chal","year":"2016","unstructured":"Chal J, Al Tanoury Z, Hestin M, Gobert B, Aivio S, Hick A, Cherrier T, Nesmith AP, Parker KK, Pourquie O (2016) Generation of human muscle fibers and satellite-like cells from human pluripotent stem cells in vitro. Nat Protoc 11(10):1833\u20131850. https:\/\/doi.org\/10.1038\/nprot.2016.110","journal-title":"Nat Protoc"},{"issue":"10","key":"4434_CR54","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1016\/j.celrep.2016.05.016","volume":"15","author":"IY Choi","year":"2016","unstructured":"Choi IY, Lim H, Estrellas K, Mula J, Cohen TV, Zhang Y, Donnelly CJ, Richard JP, Kim YJ, Kim H, Kazuki Y, Oshimura M, Li HL, Hotta A, Rothstein J, Maragakis N, Wagner KR, Lee G (2016) Concordant but varied phenotypes among Duchenne muscular dystrophy patient-specific myoblasts derived using a human IPSC-based model. Cell Rep 15(10):2301\u20132312. https:\/\/doi.org\/10.1016\/j.celrep.2016.05.016","journal-title":"Cell Rep"},{"issue":"8","key":"4434_CR55","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1002\/stem.1402","volume":"31","author":"RW Arpke","year":"2013","unstructured":"Arpke RW, Darabi R, Mader TL, Zhang Y, Toyama A, Lonetree CL, Nash N, Lowe DA, Perlingeiro RC, Kyba M (2013) A new immuno-, dystrophin-deficient model, the NSG-mdx(4Cv) mouse, provides evidence for functional improvement following allogeneic satellite cell transplantation. Stem Cells 31(8):1611\u20131620. https:\/\/doi.org\/10.1002\/stem.1402","journal-title":"Stem Cells"},{"issue":"1","key":"4434_CR56","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/s41556-017-0010-2","volume":"20","author":"MR Hicks","year":"2018","unstructured":"Hicks MR, Hiserodt J, Paras K, Fujiwara W, Eskin A, Jan M, Xi H, Young CS, Evseenko D, Nelson SF, Spencer MJ, Handel BV, Pyle AD (2018) ERBB3 and NGFR mark a distinct skeletal muscle progenitor cell in human development and hPSCs. Nat Cell Biol 20(1):46\u201357. https:\/\/doi.org\/10.1038\/s41556-017-0010-2","journal-title":"Nat Cell Biol"},{"issue":"7","key":"4434_CR57","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1016\/j.celrep.2018.10.067","volume":"25","author":"J Wu","year":"2018","unstructured":"Wu J, Matthias N, Lo J, Ortiz-Vitali JL, Shieh AW, Wang SH, Darabi R (2018) A myogenic double-reporter human pluripotent stem cell line allows prospective isolation of skeletal muscle progenitors. Cell Rep 25(7):1966-1981.e1964. https:\/\/doi.org\/10.1016\/j.celrep.2018.10.067","journal-title":"Cell Rep"},{"issue":"1","key":"4434_CR58","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.ymthe.2020.09.012","volume":"29","author":"J Wu","year":"2021","unstructured":"Wu J, Matthias N, Bhalla S, Darabi R (2021) Evaluation of the therapeutic potential of human iPSCs in a murine model of VML. Mol Ther 29(1):121\u2013131. https:\/\/doi.org\/10.1016\/j.ymthe.2020.09.012","journal-title":"Mol Ther"},{"issue":"4","key":"4434_CR59","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.stemcr.2021.03.004","volume":"16","author":"M Nalbandian","year":"2021","unstructured":"Nalbandian M, Zhao M, Sasaki-Honda M, Jonouchi T, Lucena-Cacace A, Mizusawa T, Yasuda M, Yoshida Y, Hotta A, Sakurai H (2021) Characterization of hiPSC-derived muscle progenitors reveals distinctive markers for myogenic cell purification toward cell therapy. Stem Cell Rep 16(4):883\u2013898. https:\/\/doi.org\/10.1016\/j.stemcr.2021.03.004","journal-title":"Stem Cell Rep"},{"issue":"1","key":"4434_CR60","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1038\/s41467-017-01359-w","volume":"8","author":"G Giacomazzi","year":"2017","unstructured":"Giacomazzi G, Holvoet B, Trenson S, Caluwe E, Kravic B, Grosemans H, Cortes-Calabuig A, Deroose CM, Huylebroeck D, Hashemolhosseini S, Janssens S, McNally E, Quattrocelli M, Sampaolesi M (2017) MicroRNAs promote skeletal muscle differentiation of mesodermal iPSC-derived progenitors. Nat Commun 8(1):1249. https:\/\/doi.org\/10.1038\/s41467-017-01359-w","journal-title":"Nat Commun"},{"issue":"7","key":"4434_CR61","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/s41419-021-03936-w","volume":"12","author":"N Breuls","year":"2021","unstructured":"Breuls N, Giarratana N, Yedigaryan L, Garrido GM, Carai P, Heymans S, Ranga A, Deroose C, Sampaolesi M (2021) Valproic acid stimulates myogenesis in pluripotent stem cell-derived mesodermal progenitors in a NOTCH-dependent manner. Cell Death Dis 12(7):677. https:\/\/doi.org\/10.1038\/s41419-021-03936-w","journal-title":"Cell Death Dis"},{"key":"4434_CR62","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.70341","author":"D Guo","year":"2022","unstructured":"Guo D, Daman K, Chen JJ, Shi MJ, Yan J, Matijasevic Z, Rickard AM, Bennett MH, Kiselyov A, Zhou H, Bang AG, Wagner KR, Maehr R, King OD, Hayward LJ, Emerson CP Jr (2022) iMyoblasts for ex vivo and in vivo investigations of human myogenesis and disease modeling. Elife. https:\/\/doi.org\/10.7554\/eLife.70341","journal-title":"Elife"},{"issue":"1","key":"4434_CR63","doi-asserted-by":"publisher","first-page":"3462","DOI":"10.1038\/s41598-017-03703-y","volume":"7","author":"T Laumonier","year":"2017","unstructured":"Laumonier T, Bermont F, Hoffmeyer P, Kindler V, Menetrey J (2017) Human myogenic reserve cells are quiescent stem cells that contribute to muscle regeneration after intramuscular transplantation in immunodeficient mice. Sci Rep 7(1):3462. https:\/\/doi.org\/10.1038\/s41598-017-03703-y","journal-title":"Sci Rep"},{"issue":"4","key":"4434_CR64","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.stem.2022.03.004","volume":"29","author":"C Sun","year":"2022","unstructured":"Sun C, Kannan S, Choi IY, Lim H, Zhang H, Chen GS, Zhang N, Park SH, Serra C, Iyer SR, Lloyd TE, Kwon C, Lovering RM, Lim SB, Andersen P, Wagner KR, Lee G (2022) Human pluripotent stem cell-derived myogenic progenitors undergo maturation to quiescent satellite cells upon engraftment. Cell Stem Cell 29(4):610-619.e615. https:\/\/doi.org\/10.1016\/j.stem.2022.03.004","journal-title":"Cell Stem Cell"},{"issue":"6","key":"4434_CR65","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/0092-8674(87)90585-x","volume":"51","author":"RL Davis","year":"1987","unstructured":"Davis RL, Weintraub H, Lassar AB (1987) Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell 51(6):987\u20131000. https:\/\/doi.org\/10.1016\/0092-8674(87)90585-x","journal-title":"Cell"},{"issue":"5","key":"4434_CR66","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/0092-8674(86)90507-6","volume":"47","author":"AB Lassar","year":"1986","unstructured":"Lassar AB, Paterson BM, Weintraub H (1986) Transfection of a DNA locus that mediates the conversion of 10T1\/2 fibroblasts to myoblasts. Cell 47(5):649\u2013656. https:\/\/doi.org\/10.1016\/0092-8674(86)90507-6","journal-title":"Cell"},{"issue":"14","key":"4434_CR67","doi-asserted-by":"publisher","first-page":"5434","DOI":"10.1073\/pnas.86.14.5434","volume":"86","author":"H Weintraub","year":"1989","unstructured":"Weintraub H, Tapscott SJ, Davis RL, Thayer MJ, Adam MA, Lassar AB, Miller AD (1989) Activation of muscle-specific genes in pigment, nerve, fat, liver, and fibroblast cell lines by forced expression of MyoD. Proc Natl Acad Sci U S A 86(14):5434\u20135438. https:\/\/doi.org\/10.1073\/pnas.86.14.5434","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"4434_CR68","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1038\/mt.2012.188","volume":"20","author":"S Goudenege","year":"2012","unstructured":"Goudenege S, Lebel C, Huot NB, Dufour C, Fujii I, Gekas J, Rousseau J, Tremblay JP (2012) Myoblasts derived from normal hESCs and dystrophic hiPSCs efficiently fuse with existing muscle fibers following transplantation. Mol Ther 20(11):2153\u20132167. https:\/\/doi.org\/10.1038\/mt.2012.188","journal-title":"Mol Ther"},{"issue":"140","key":"4434_CR69","doi-asserted-by":"publisher","first-page":"140ra189","DOI":"10.1126\/scitranslmed.3003541","volume":"4","author":"FS Tedesco","year":"2012","unstructured":"Tedesco FS, Gerli MF, Perani L, Benedetti S, Ungaro F, Cassano M, Antonini S, Tagliafico E, Artusi V, Longa E, Tonlorenzi R, Ragazzi M, Calderazzi G, Hoshiya H, Cappellari O, Mora M, Schoser B, Schneiderat P, Oshimura M, Bottinelli R, Sampaolesi M, Torrente Y, Broccoli V, Cossu G (2012) Transplantation of genetically corrected human iPSC-derived progenitors in mice with limb-girdle muscular dystrophy. Sci Transl Med 4(140):140ra189. https:\/\/doi.org\/10.1126\/scitranslmed.3003541","journal-title":"Sci Transl Med"},{"issue":"3","key":"4434_CR70","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.celrep.2018.03.091","volume":"23","author":"SM Maffioletti","year":"2018","unstructured":"Maffioletti SM, Sarcar S, Henderson ABH, Mannhardt I, Pinton L, Moyle LA, Steele-Stallard H, Cappellari O, Wells KE, Ferrari G, Mitchell JS, Tyzack GE, Kotiadis VN, Khedr M, Ragazzi M, Wang W, Duchen MR, Patani R, Zammit PS, Wells DJ, Eschenhagen T, Tedesco FS (2018) Three-dimensional human iPSC-derived artificial skeletal muscles model muscular dystrophies and enable multilineage tissue engineering. Cell Rep 23(3):899\u2013908. https:\/\/doi.org\/10.1016\/j.celrep.2018.03.091","journal-title":"Cell Rep"},{"key":"4434_CR71","doi-asserted-by":"publisher","first-page":"e50532","DOI":"10.3791\/50532","volume":"83","author":"MF Gerli","year":"2014","unstructured":"Gerli MF, Maffioletti SM, Millet Q, Tedesco FS (2014) Transplantation of induced pluripotent stem cell-derived mesoangioblast-like myogenic progenitors in mouse models of muscle regeneration. J Vis Exp 83:e50532. https:\/\/doi.org\/10.3791\/50532","journal-title":"J Vis Exp"},{"issue":"2","key":"4434_CR72","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.stemcr.2019.06.006","volume":"13","author":"T Sato","year":"2019","unstructured":"Sato T, Higashioka K, Sakurai H, Yamamoto T, Goshima N, Ueno M, Sotozono C (2019) Core transcription factors promote induction of PAX3-positive skeletal muscle stem cells. Stem Cell Rep 13(2):352\u2013365. https:\/\/doi.org\/10.1016\/j.stemcr.2019.06.006","journal-title":"Stem Cell Rep"},{"issue":"4","key":"4434_CR73","doi-asserted-by":"publisher","first-page":"e61540","DOI":"10.1371\/journal.pone.0061540","volume":"8","author":"A Tanaka","year":"2013","unstructured":"Tanaka A, Woltjen K, Miyake K, Hotta A, Ikeya M, Yamamoto T, Nishino T, Shoji E, Sehara-Fujisawa A, Manabe Y, Fujii N, Hanaoka K, Era T, Yamashita S, Isobe K, Kimura E, Sakurai H (2013) Efficient and reproducible myogenic differentiation from human iPS cells: prospects for modeling Miyoshi Myopathy in vitro. PLoS ONE 8(4):e61540. https:\/\/doi.org\/10.1371\/journal.pone.0061540","journal-title":"PLoS ONE"},{"key":"4434_CR74","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.semcdb.2017.11.010","volume":"72","author":"JM Hernandez-Hernandez","year":"2017","unstructured":"Hernandez-Hernandez JM, Garcia-Gonzalez EG, Brun CE, Rudnicki MA (2017) The myogenic regulatory factors, determinants of muscle development, cell identity and regeneration. Semin Cell Dev Biol 72:10\u201318. https:\/\/doi.org\/10.1016\/j.semcdb.2017.11.010","journal-title":"Semin Cell Dev Biol"},{"key":"4434_CR75","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3389\/fcell.2017.00046","volume":"5","author":"F Hernandez-Torres","year":"2017","unstructured":"Hernandez-Torres F, Rodriguez-Outeirino L, Franco D, Aranega AE (2017) Pitx2 in embryonic and adult myogenesis. Front Cell Dev Biol 5:46. https:\/\/doi.org\/10.3389\/fcell.2017.00046","journal-title":"Front Cell Dev Biol"},{"issue":"12","key":"4434_CR76","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1242\/dev.151035","volume":"144","author":"J Chal","year":"2017","unstructured":"Chal J, Pourquie O (2017) Making muscle: skeletal myogenesis in vivo and in vitro. Development 144(12):2104\u20132122. https:\/\/doi.org\/10.1242\/dev.151035","journal-title":"Development"},{"issue":"7044","key":"4434_CR77","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1038\/nature03572","volume":"435","author":"J Gros","year":"2005","unstructured":"Gros J, Manceau M, Thome V, Marcelle C (2005) A common somitic origin for embryonic muscle progenitors and satellite cells. Nature 435(7044):954\u2013958. https:\/\/doi.org\/10.1038\/nature03572","journal-title":"Nature"},{"issue":"12","key":"4434_CR78","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1101\/gad.345505","volume":"19","author":"L Kassar-Duchossoy","year":"2005","unstructured":"Kassar-Duchossoy L, Giacone E, Gayraud-Morel B, Jory A, Gomes D, Tajbakhsh S (2005) Pax3\/Pax7 mark a novel population of primitive myogenic cells during development. Genes Dev 19(12):1426\u20131431. https:\/\/doi.org\/10.1101\/gad.345505","journal-title":"Genes Dev"},{"issue":"16","key":"4434_CR79","doi-asserted-by":"publisher","first-page":"3430","DOI":"10.1038\/sj.emboj.7600346","volume":"23","author":"S Oustanina","year":"2004","unstructured":"Oustanina S, Hause G, Braun T (2004) Pax7 directs postnatal renewal and propagation of myogenic satellite cells but not their specification. EMBO J 23(16):3430\u20133439. https:\/\/doi.org\/10.1038\/sj.emboj.7600346","journal-title":"EMBO J"},{"issue":"9","key":"4434_CR80","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1101\/gad.301004","volume":"18","author":"F Relaix","year":"2004","unstructured":"Relaix F, Rocancourt D, Mansouri A, Buckingham M (2004) Divergent functions of murine Pax3 and Pax7 in limb muscle development. Genes Dev 18(9):1088\u20131105. https:\/\/doi.org\/10.1101\/gad.301004","journal-title":"Genes Dev"},{"issue":"5","key":"4434_CR81","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.stem.2012.02.015","volume":"10","author":"R Darabi","year":"2012","unstructured":"Darabi R, Arpke RW, Irion S, Dimos JT, Grskovic M, Kyba M, Perlingeiro RC (2012) Human ES- and iPS-derived myogenic progenitors restore DYSTROPHIN and improve contractility upon transplantation in dystrophic mice. Cell Stem Cell 10(5):610\u2013619. https:\/\/doi.org\/10.1016\/j.stem.2012.02.015","journal-title":"Cell Stem Cell"},{"issue":"13","key":"4434_CR82","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.1016\/j.celrep.2017.06.005","volume":"19","author":"A Magli","year":"2017","unstructured":"Magli A, Incitti T, Kiley J, Swanson SA, Darabi R, Rinaldi F, Selvaraj S, Yamamoto A, Tolar J, Yuan C, Stewart R, Thomson JA, Perlingeiro RCR (2017) PAX7 Targets, CD54, integrin alpha9beta1, and SDC2, allow isolation of human ESC\/iPSC-derived myogenic progenitors. Cell Rep 19(13):2867\u20132877. https:\/\/doi.org\/10.1016\/j.celrep.2017.06.005","journal-title":"Cell Rep"},{"key":"4434_CR83","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.47970","author":"S Selvaraj","year":"2019","unstructured":"Selvaraj S, Mondragon-Gonzalez R, Xu B, Magli A, Kim H, Laine J, Kiley J, McKee H, Rinaldi F, Aho J, Tabti N, Shen W, Perlingeiro RC (2019) Screening identifies small molecules that enhance the maturation of human pluripotent stem cell-derived myotubes. Elife. https:\/\/doi.org\/10.7554\/eLife.47970","journal-title":"Elife"},{"issue":"6","key":"4434_CR84","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1016\/j.celrep.2017.01.040","volume":"18","author":"H Xi","year":"2017","unstructured":"Xi H, Fujiwara W, Gonzalez K, Jan M, Liebscher S, Van Handel B, Schenke-Layland K, Pyle AD (2017) In vivo human somitogenesis guides somite development from hPSCs. Cell Rep 18(6):1573\u20131585. https:\/\/doi.org\/10.1016\/j.celrep.2017.01.040","journal-title":"Cell Rep"},{"issue":"1","key":"4434_CR85","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.stemcr.2017.04.022","volume":"9","author":"J Kim","year":"2017","unstructured":"Kim J, Magli A, Chan SSK, Oliveira VKP, Wu J, Darabi R, Kyba M, Perlingeiro RCR (2017) Expansion and purification are critical for the therapeutic application of pluripotent stem cell-derived myogenic progenitors. Stem Cell Rep 9(1):12\u201322. https:\/\/doi.org\/10.1016\/j.stemcr.2017.04.022","journal-title":"Stem Cell Rep"},{"issue":"2","key":"4434_CR86","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1634\/stemcells.2007-0039","volume":"26","author":"JR Smith","year":"2008","unstructured":"Smith JR, Maguire S, Davis LA, Alexander M, Yang F, Chandran S, Ffrench-Constant C, Pedersen RA (2008) Robust, persistent transgene expression in human embryonic stem cells is achieved with AAVS1-targeted integration. Stem Cells 26(2):496\u2013504. https:\/\/doi.org\/10.1634\/stemcells.2007-0039","journal-title":"Stem Cells"},{"issue":"1","key":"4434_CR87","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.stemcr.2020.11.001","volume":"16","author":"H Kim","year":"2021","unstructured":"Kim H, Selvaraj S, Kiley J, Azzag K, Garay BI, Perlingeiro RCR (2021) Genomic safe harbor expression of PAX7 for the generation of engraftable myogenic progenitors. Stem Cell Rep 16(1):10\u201319. https:\/\/doi.org\/10.1016\/j.stemcr.2020.11.001","journal-title":"Stem Cell Rep"},{"key":"4434_CR88","doi-asserted-by":"publisher","first-page":"102333","DOI":"10.1016\/j.scr.2021.102333","volume":"53","author":"AJ Mateos-Aierdi","year":"2021","unstructured":"Mateos-Aierdi AJ, Dehesa-Etxebeste M, Goicoechea M, Aiastui A, Richaud-Patin Y, Jimenez-Delgado S, Raya A, Naldaiz-Gastesi N, Lopez de Munain A (2021) Patient-specific iPSC-derived cellular models of LGMDR1. Stem Cell Res 53:102333. https:\/\/doi.org\/10.1016\/j.scr.2021.102333","journal-title":"Stem Cell Res"},{"issue":"1","key":"4434_CR89","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/s41467-017-02636-4","volume":"9","author":"L Rao","year":"2018","unstructured":"Rao L, Qian Y, Khodabukus A, Ribar T, Bursac N (2018) Engineering human pluripotent stem cells into a functional skeletal muscle tissue. Nat Commun 9(1):126. https:\/\/doi.org\/10.1038\/s41467-017-02636-4","journal-title":"Nat Commun"},{"issue":"4","key":"4434_CR90","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.stem.2016.01.021","volume":"18","author":"CS Young","year":"2016","unstructured":"Young CS, Hicks MR, Ermolova NV, Nakano H, Jan M, Younesi S, Karumbayaram S, Kumagai-Cresse C, Wang D, Zack JA, Kohn DB, Nakano A, Nelson SF, Miceli MC, Spencer MJ, Pyle AD (2016) A single CRISPR-Cas9 deletion strategy that targets the majority of DMD patients restores dystrophin function in hiPSC-derived muscle cells. Cell Stem Cell 18(4):533\u2013540. https:\/\/doi.org\/10.1016\/j.stem.2016.01.021","journal-title":"Cell Stem Cell"},{"issue":"12","key":"4434_CR91","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1016\/j.ymthe.2019.08.011","volume":"27","author":"S Selvaraj","year":"2019","unstructured":"Selvaraj S, Dhoke NR, Kiley J, Mateos-Aierdi AJ, Tungtur S, Mondragon-Gonzalez R, Killeen G, Oliveira VKP, Lopez de Munain A, Perlingeiro RCR (2019) Gene correction of LGMD2A patient-specific iPSCs for the development of targeted autologous cell therapy. Mol Ther 27(12):2147\u20132157. https:\/\/doi.org\/10.1016\/j.ymthe.2019.08.011","journal-title":"Mol Ther"},{"issue":"2","key":"4434_CR92","doi-asserted-by":"publisher","first-page":"109360","DOI":"10.1016\/j.celrep.2021.109360","volume":"36","author":"NR Dhoke","year":"2021","unstructured":"Dhoke NR, Kim H, Selvaraj S, Azzag K, Zhou H, Oliveira NAJ, Tungtur S, Ortiz-Cordero C, Kiley J, Lu QL, Bang AG, Perlingeiro RCR (2021) A universal gene correction approach for FKRP-associated dystroglycanopathies to enable autologous cell therapy. Cell Rep 36(2):109360. https:\/\/doi.org\/10.1016\/j.celrep.2021.109360","journal-title":"Cell Rep"},{"issue":"11","key":"4434_CR93","doi-asserted-by":"publisher","first-page":"8463","DOI":"10.1128\/jvi.72.11.8463-8471.1998","volume":"72","author":"T Dull","year":"1998","unstructured":"Dull T, Zufferey R, Kelly M, Mandel RJ, Nguyen M, Trono D, Naldini L (1998) A third-generation lentivirus vector with a conditional packaging system. J Virol 72(11):8463\u20138471. https:\/\/doi.org\/10.1128\/jvi.72.11.8463-8471.1998","journal-title":"J Virol"},{"issue":"7","key":"4434_CR94","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1038\/s41375-018-0106-0","volume":"32","author":"MC Milone","year":"2018","unstructured":"Milone MC, O\u2019Doherty U (2018) Clinical use of lentiviral vectors. Leukemia 32(7):1529\u20131541. https:\/\/doi.org\/10.1038\/s41375-018-0106-0","journal-title":"Leukemia"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-022-04434-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00018-022-04434-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-022-04434-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T23:03:27Z","timestamp":1661209407000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00018-022-04434-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,8]]},"references-count":94,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["4434"],"URL":"https:\/\/doi.org\/10.1007\/s00018-022-04434-8","relation":{},"ISSN":["1420-682X","1420-9071"],"issn-type":[{"value":"1420-682X","type":"print"},{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,8]]},"assertion":[{"value":"17 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there are no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"406"}}